Key Points
Wealthsimple launched IPO Access allowing Canadian retail investors to buy at offering prices.
SpaceX priced at $135 USD per share with 555.6 million Class A shares planned for Nasdaq.
No minimum order size or additional fees for eligible Wealthsimple Trade account holders.
IPO shares can trade below offering price after listing, creating real downside risk.
Wealthsimple launched a new IPO Access feature that lets Canadian retail investors request shares in select public offerings at the launch price before trading begins. The platform started with Apotex Health Corp. and added SpaceX on Thursday, June 04. This shift breaks down barriers that once locked everyday investors out of IPO allocations reserved for institutions and wealthy clients.
How Wealthsimple’s IPO Access Works
Eligible Wealthsimple Trade account holders can request shares with no minimum order size and no additional fees. Investors pay only the final IPO price set by the company. For SpaceX, the price is $135 USD per share. Allocation results arrive on the morning of the IPO date for U.S. offerings. The feature applies to both Canadian and U.S. IPOs, though U.S.-only offerings require accredited investor status under Canadian securities law.
SpaceX Sets Record IPO Terms
SpaceX plans to sell 555.6 million Class A shares on the Nasdaq under ticker SPCX, with trading possibly starting June 12. The company locked in the $135 USD price upfront due to strong demand. SpaceX set aside up to 30% of shares for retail investors through brokers like Fidelity and SoFi. The company pulled in $18.7 billion in 2025 revenue, mostly from Starlink. Goldman Sachs projects revenue could reach $474 billion by 2030.
Retail Access Expands, But Experts Warn Caution
Jonathan Platt, a 27-year-old pharmacy graduate, requested 345 Apotex shares at $20 to $24 per share, an estimated $10,000 investment. He said he would have waited months without IPO Access. Benjamin Felix, chief investment officer at PWL Capital, cautioned that democratizing exotic products can hurt retail investors. IPO excitement builds around Apotex, SpaceX and Anthropic as platforms race to offer earlier access to public offerings.
Key Risks for IPO Investors
IPO shares can trade below the offering price once the company lists. There is no guarantee of gains, and significant losses are possible. Wealthsimple warns that shares can lose value quickly. Investors must have enough settled cash in their account to cover requested shares and maintain good account standing.
Final Thoughts
Wealthsimple’s IPO Access levels the playing field for Canadian retail investors, but comes with real risks. Shares can drop below the IPO price after listing, so investors must do their homework before committing capital.
FAQs
It allows eligible Wealthsimple Trade users to request shares in select IPOs at the offering price before public trading begins, with no minimum order size or fees.
SpaceX shares are priced at $135 USD per share and will trade on Nasdaq under ticker SPCX, with trading expected to start June 12.
You need a Wealthsimple Trade account in good standing, sufficient settled cash for shares, and accredited investor status for U.S.-only IPOs under Canadian securities law.
Disclaimer:
The content shared by Meyka AI PTY LTD is solely for research and informational purposes. Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.
About Author

Danny Kontos
Co FounderDanny Kontos has been a stock investor since 2007 and co-founded Meyka in 2023. He keeps a small, focused portfolio and only moves when the numbers are hard to argue with. He has waited years on a single position before. Before Meyka, he ran a web hosting company and a mortgage lending platform, so he knows what a well-run business actually looks like under the hood. This article did not come from a news cycle. It came from someone who has been watching this space for a long time.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask Meyka Analyst about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)